Glymphatic System in Ocular Diseases: Evaluation of MRI Findings

References

1. 1.↵
   1. Brinker T,
   2. Stopa E,
   3. Morrison J, et al

   . A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 2014;11:10 doi:10.1186/2045-8118-11-10 pmid:24817998

   CrossRefPubMed
2. 2.↵
   1. Deike-Hofmann K,
   2. Reuter J,
   3. Haase R, et al

   . Glymphatic pathway of gadolinium-based contrast agents through the brain: overlooked and misinterpreted. Invest Radiol 2018;54:229–37 doi:10.1097/RLI.0000000000000533 pmid:24817998

   CrossRefPubMed
3. 3.↵
   1. Wostyn P,
   2. De Groot V,
   3. Van Dam D, et al

   . The glymphatic hypothesis of glaucoma: a unifying concept incorporating vascular, biomechanical, and biochemical aspects of the disease. Biomed Res Int 2017;2017:5123148 doi:10.1155/2017/5123148 pmid:28948167

   CrossRefPubMed
4. 4.↵
   1. Galmiche C,
   2. Moal B,
   3. Marnat G, et al

   . Delayed gadolinium leakage in ocular structures: a potential marker for age- and vascular risk factor-related small vessel disease? Invest Radiol 2021;56:425–32 doi:10.1097/RLI.0000000000000757 pmid:33481460

   CrossRefPubMed
5. 5.↵
   1. Förster A,
   2. Böhme J,
   3. Groden C, et al

   . Gadolinium leakage in ocular structures in optic neuritis. J Clin Neurosci 2019;68:268–70 doi:10.1016/j.jocn.2019.05.050 pmid:31204221

   CrossRefPubMed
6. 6.↵
   1. Herrera DA,
   2. Franco S,
   3. Bustamante S, et al

   . Contrast-enhanced T2-FLAIR MR imaging in patients with uveitis. Int Ophthalmol 2017;37:507–12 doi:10.1007/s10792-016-0289-1 pmid:27405314

   CrossRefPubMed
7. 7.↵
   1. Deike-Hofmann K,
   2. von Lampe P,
   3. Schlemmer HP, et al

   . The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents? Eur Radiol 2020;30:4633–40 doi:10.1007/s00330-020-06762-4 pmid:32179994

   CrossRefPubMed
8. 8.↵
   1. Taoka T,
   2. Naganawa S

   . Gadolinium-based contrast media, cerebrospinal fluid and the glymphatic system: possible mechanisms for the deposition of gadolinium in the brain. Magn Reson Med Sci 2018;17:111–19 doi:10.2463/mrms.rev.2017-0116 pmid:29367513

   CrossRefPubMed
9. 9.↵
   1. Pardridge WM

   . CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv 2016;13:963–75 doi:10.1517/17425247.2016.1171315 pmid:27020469

   CrossRefPubMed
10. 10.↵
    1. Wostyn P,
    2. Van Dam D,
    3. Audenaert K, et al

    . A new glaucoma hypothesis: a role of glymphatic system dysfunction. Fluids Barriers CNS 2015;12:16 doi:10.1186/s12987-015-0012-z pmid:26118970

    CrossRefPubMed
11. 11.↵
    1. Naganawa S,
    2. Kawai H,
    3. Taoka T, et al

    . Heavily T2-weighted 3D-FLAIR improves the detection of cochlear lymph fluid signal abnormalities in patients with sudden sensorineural hearing loss. Magn Reson Med Sci 2016;15:203–11 doi:10.2463/mrms.mp.2015-0065 pmid:26597430

    CrossRefPubMed
12. 12.↵
    1. Hitomi E,
    2. Simpkins AN,
    3. Luby M, et al

    . Blood-ocular barrier disruption in patients with acute stroke. Neurology 2018;90:e915–23 doi:10.1212/WNL.0000000000005123 pmid:29438039

    Abstract/FREE Full Text
13. 13.↵
    1. Jones O,
    2. Cutsforth-Gregory J,
    3. Chen J, et al

    . Idiopathic intracranial hypertension is associated with a higher burden of visible cerebral perivascular spaces: the glymphatic connection. AJNR Am J Neuroradiol 2021;42:2160–64 doi:10.3174/ajnr.A7326 pmid:34824096

    Abstract/FREE Full Text
14. 14.↵
    1. Shinohara RT,
    2. Sweeney EM,
    3. Goldsmith J, et al

    . Statistical normalization techniques for magnetic resonance imaging. Neuroimage Clin 2014;6:9–19 doi:10.1016/j.nicl.2014.08.008 pmid:25379412

    CrossRefPubMed
15. 15.↵
    1. Bill A

    . Capillary permeability to and extravascular dynamics of myoglobin, albumin and gammaglobulin in the uvea. Acta Physiol Scand 1968;73:204–19 doi:10.1111/j.1748-1716.1968.tb04097.x pmid:4175033

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Jacobsen HH,
    2. Ringstad G,
    3. Jørstad ØK, et al

    . The human visual pathway communicates directly with the subarachnoid space. Invest Ophthalmol Vis Sci 2019;60:2773– 80 doi:10.1167/iovs.19-26997 pmid:31247084

    CrossRefPubMed
17. 17.↵
    1. Jacobsen HH,
    2. Sandell T,
    3. Jørstad ØK, et al

    . In vivo evidence for impaired glymphatic function in the visual pathway of patients with normal pressure hydrocephalus. Invest Ophthalmol Vis Sci 2020;61:24 doi:10.1167/iovs.61.13.24 pmid:33201186

    CrossRefPubMed